Exotome
Optimizing cancer surgeries using dual-acting imaging and ablation agent
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location San Diego, CA, USA
- Currency USD
- Founded April 2019
- Employees 4
- Incorporation Type C-corp
- Website exotome.us
Company Summary
Exo-413, developed at the laboratory of molecular imaging pioneer Prof. James Basilion at Case Western Reserve Univ. using over $2.5M of grants, is the world's only agent capable of both imaging and ablation of prostate cancer tumors. Exotome, founded by experienced clinical trial executives, is seeking $1.5M to advance to human studies. A Series A round of $5M will suffice to obtain Phase II data by 2023. Comparable exits are at $50M+ range.
Team
-
Business DevelopmentSenior healthcare executive with operational, legal and deal-making expertise developed in large healthcare corporations and as founder and CEO of healthcare startups.
Wharton MBA
Led $500M+ deals for Omnicell Inc., Edwards Lifesciences
GM, Omnicell Germany ($30M sales, 130 employees)
CEO of MicroMRI, imaging company merged with Bioclinica
Attorney
-
Ari AminetzahCEOA savvy Life Sciences executive and serial entrepreneur with more than 25 years of international broad leadership and management experience in both early and clinical-stage pharmaceutical, diagnostics and medical device companies.
CBO, Tracer CRO
Advisor to J&J Executive Board, Dutch government, McKinsey & Co.
SVP Innovation, Crucell (sold to J&J for $2.7B (inc. prostate cancer vaccine)
CEO, SPL (oncology imaging), sold to Bender Groupe
-
Prof. Go Van DamCSOA surgeon from the Academic Medical Center in Groningen in the Netherlands, a pioneer and a world expert in the field of Optical imaging.
Prof. of Surgery, Nuclear Medicine and Molecular Imaging
Co-Founder of American and Intl. Societies of Image Guided Surgery
155 publications inc. top 1% cited in NEJMAppointments at Harvard, NIH/NCI Mayo Clinic, UCSD
CEO, Tracer CRO, the world's leading microdosing CRO
-
Co-FounderProfessor of Radiology and Biomedical Engineering at Case Western Reserve has been in the field of optical molecular imaging since the early 1990s and has just retired as the president of the World Molecular Imaging Society.
Prof. of Bioengineering, Pathology, CWRU
Co-Founder: American Academy of Nanomedicine, World Molecular Imaging Society
Previously consultant to Eli Lilly, Novartis, Variagenics, UBS Warburg
Advisors
-
Prof. Lee Ponsky, Chair, Dept. of Urology, CWRUUnconfirmed
Eben Rosenthal, MD, PhD, Surgery/Radiology, Stanford Cancer CenterUnconfirmed
Previous Investors
-
Jennifer Spohr, 3rd Frontier Fund, Ohio Development ProgramUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.